Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group (Q44145974)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 1998
edit
Language Label Description Also known as
English
Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group
scientific article published in February 1998

    Statements

    Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group (English)
    C Brun-Buisson
    J P Sollet
    H Schweich
    S Brière
    C Petit
    1 February 1998
    346-354

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit